| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 09/20/1995 | EP0671951A1 Humanized antibodies reactive with l-selectin |
| 09/20/1995 | EP0671947A1 Compositions for eliciting cytotoxic t-lymphocyte responses against viruses |
| 09/20/1995 | EP0671946A1 Immunoreactive peptides from epstein-barr virus |
| 09/20/1995 | EP0671933A1 Novel uses of il-10 |
| 09/20/1995 | EP0671927A1 Human neutralizing monoclonal antibodies to respiratory syncytial virus |
| 09/20/1995 | EP0563358B1 9-substituted bicyclo [3.3.0]octane derivatives, for use as txa2 antagonists |
| 09/20/1995 | EP0536343B1 Targeted polymeric conjugates of cyclosporin and method for their preparation |
| 09/20/1995 | EP0458965B1 Process for the preparation of vinyl ethers |
| 09/20/1995 | EP0364559B1 Substituted adenine derivatives useful as therapeutic agents |
| 09/20/1995 | CN1108655A 1,3-oxathiolane nucleoside analogues |
| 09/20/1995 | CN1108529A Rapamycin formulations for oral administration |
| 09/19/1995 | US5451700 Leukotriene inhibitors |
| 09/19/1995 | US5451412 Biologically active undenatured whey protein concentrate as food supplement |
| 09/19/1995 | CA1337073C 4 amino quinolines and naphthyridines, process for their preparation and their use as medicines |
| 09/14/1995 | WO1995024501A1 Compositions for the inhibition of tnf formation and uses thereof |
| 09/14/1995 | WO1995024485A2 Coordinate in vivo gene expression |
| 09/14/1995 | WO1995024481A2 Humanized monoclonal antibodies against human interleukin-4 |
| 09/14/1995 | WO1995024408A1 Benzothiophene, benzofuran and indolethiazepinones, oxazepinones and diazepinones as inhibitors of cell adhesion and as inhibitors of hiv |
| 09/14/1995 | WO1995024398A1 Isoxazoline compounds as inhibitors of tnf release |
| 09/14/1995 | WO1995024397A1 3,5-disubstituted and 3,5,6-trisubstituted 2-isoxazolines and isoxazoles, process for preparing the same and their use as medicaments |
| 09/14/1995 | WO1995024395A1 Quinoline derivatives as immunomodulators |
| 09/14/1995 | WO1995024381A1 Cyano compounds and preparations thereof |
| 09/14/1995 | WO1995024217A1 Methods for modulating t cell unresponsiveness |
| 09/14/1995 | WO1995024213A1 Method of stimulating hematopoiesis with hemoglobin |
| 09/14/1995 | WO1995024192A1 Isoxazoline compounds as 5-lipoxygenase inhibitors |
| 09/14/1995 | DE4408084A1 3,5-Disubstituierte und 3,4,5-trisubstituierte 2-Isoxazoline und Isoxazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel 3,5-Disubstituted and 3,4,5-trisubstituted 2-isoxazolines and isoxazoles, to processes for their preparation and their use as medicaments |
| 09/14/1995 | CA2214521A1 Quinoline derivatives as immunomodulators |
| 09/14/1995 | CA2185162A1 Compositions for the inhibition of tnf formation and uses thereof |
| 09/14/1995 | CA2185027A1 Methods for modulating t cell unresponsiveness |
| 09/14/1995 | CA2185004A1 3,5-disubstituted and 3,4,5-trisubstituted 2-isoxazolines and isoxazoles, process for preparing the same and their use as medicaments |
| 09/14/1995 | CA2182800A1 Method of stimulating hematopoiesis with hemoglobin |
| 09/14/1995 | CA2181354A1 Benzothiophene, benzofuran and indole-thiazepinones, oxazepinones and diazepinones as inhibitors of cell adhesion and as inhibitors of hiv |
| 09/13/1995 | EP0671407A2 Sulfated alpha-glycolipid derivatives as cell adhesion inhibitors |
| 09/13/1995 | EP0671005A1 Rxr homodimer formation and bridged bicyclic aromatic compounds and their use in modulating gene expression |
| 09/13/1995 | EP0670905A1 Recombinant viruses displaying a nonviral polypeptide on their external surface |
| 09/13/1995 | EP0670738A1 Methods for enhancing vascularization of implant devices |
| 09/13/1995 | EP0670733A1 Compositions containing growth factors and antiplastic agents |
| 09/13/1995 | EP0670727A1 Compounds that inhibit t cell proliferation and methods using the same |
| 09/13/1995 | EP0670720A1 Enzyme inhibitors |
| 09/13/1995 | EP0541706B1 Process and intermediate for the preparation of 2-hydroxy-3-sulfido-3-phenyl propanoic acids |
| 09/13/1995 | EP0541593B1 Cyclopentane derivatives, process for producing them and their pharmaceutical use |
| 09/13/1995 | EP0429627B1 Derivatives of quinoline-3-carboxanilide |
| 09/13/1995 | CN1108247A Compounds |
| 09/13/1995 | CN1108102A Methods of inhibiting autoimmune diseases |
| 09/13/1995 | CN1108096A Non-peptide tachykinin receptor antagonists |
| 09/13/1995 | CN1108092A Methods of increasing macrophage function |
| 09/12/1995 | US5449798 Phospholipid derivatives containing higher elements of the fifth group |
| 09/12/1995 | US5449693 Benzene derivatives, their preparation and pharmaceutical compositions in which they are present |
| 09/12/1995 | US5449686 4-phenylcyclohexanone derivatives; inhibit production of tumor necrosis factor and phosphodiesterase V |
| 09/12/1995 | US5449522 Antitumor |
| 09/12/1995 | CA1336954C Treatment of autoimmune diseases by oral administration of autoantigens |
| 09/08/1995 | WO1995023867A1 Integrative recombinant adenoviruses, preparation thereof and therapeutical uses thereof |
| 09/08/1995 | WO1995023862A1 Animals with targeted gene disruption |
| 09/08/1995 | WO1995023856A1 Chimeric complement inhibitor proteins |
| 09/08/1995 | WO1995023814A1 Product and process for t cell regulation |
| 09/08/1995 | WO1995023806A2 Ureido derivatives of naphthalenephosphonic acids and process for their preparation |
| 09/08/1995 | WO1995023797A1 Process for making an epoxide |
| 09/08/1995 | WO1995023789A1 Bicyclic carbamates as leukotriene d4 antagonists |
| 09/08/1995 | WO1995023601A1 Method and composition for topical treatment of damaged tissue using histamine phosphate as active ingredient |
| 09/08/1995 | WO1995023512A1 Terminal complement inhibitor fusion genes and proteins |
| 09/08/1995 | CA2184810A1 Product and process for t cell regulation |
| 09/08/1995 | CA2184356A1 Terminal complement inhibitor fusion genes and proteins |
| 09/08/1995 | CA2184355A1 Chimeric complement inhibitor proteins |
| 09/08/1995 | CA2184113A1 Integrative recombinant adenoviruses, preparation thereof and therapeutical uses thereof |
| 09/08/1995 | CA2160250A1 Ureido derivatives of naphthalenephosphonic acids and process for their preparation |
| 09/06/1995 | EP0670369A2 A novel peptide related to human programmed cell death and DNA encoding it |
| 09/06/1995 | EP0669983A1 Allergenic proteins and peptides from japanese cedar pollen |
| 09/06/1995 | EP0669982A1 Materials comprising and methods of preparation and use for ribosome-inactivating proteins |
| 09/06/1995 | EP0669979A1 C-c ckr-1, c-c chemokine receptor |
| 09/06/1995 | EP0669977A1 Transformed endothelial cells |
| 09/06/1995 | EP0669938A1 PEPTIDE DERIVATIVES OF $g(a)-MSH AND THEIR APPLICATION |
| 09/06/1995 | EP0669936A1 Novel mercaptoacetylamide bicyclic lactam derivatives useful as inhibitors of enkephalinase and ace |
| 09/06/1995 | EP0669914A1 Novel isoxazolines as antiinflammatory agents |
| 09/06/1995 | EP0669909A1 Substituted amidino compounds, their manufacture and methods of treatment |
| 09/06/1995 | EP0669833A1 USES OF TGF-$g(b) RECEPTOR FRAGMENT AS A THERAPEUTIC AGENT |
| 09/06/1995 | EP0669829A1 Enhancement of xenograft tolerance and porcine cytokines therefor |
| 09/06/1995 | EP0669827A1 Compositions for the regulation of cytokine activity |
| 09/05/1995 | US5447959 Vitamin A derivatives |
| 09/05/1995 | US5447934 Anti-allergic thiadiazolo [4,3-a]pyridine derivatives |
| 09/05/1995 | US5447931 New therapeutic use of heterocyclylpiperazines as 5-HT3 agonists and new compounds |
| 09/05/1995 | US5447924 Vitamin D analogues |
| 09/05/1995 | CA2142154A1 Sulfated .alpha.-glycolipid derivatives as cell adhesion inhibitors |
| 09/05/1995 | CA2010017C Composition for reparation and prevention of fibrotic lesions |
| 08/31/1995 | WO1995023234A1 Isolated, tyrosinase derived peptides and uses thereof |
| 08/31/1995 | WO1995023156A1 Structure of a novel lipid a and methods utilizing same |
| 08/31/1995 | WO1995023128A1 Diesters of carbonic acid endowed with antiviral and anti-inflammatory activity |
| 08/31/1995 | WO1995023127A1 2-(aminoalkoxy)phenylalkylamines with antiinflammatory activity |
| 08/31/1995 | WO1995022977A1 Antigen-based heteropolymers and method for treating autoimmune diseases using the same |
| 08/31/1995 | WO1995022972A1 Rapamycin derivatives |
| 08/31/1995 | CA2184283A1 Structure of a novel lipid a and methods utilizing same |
| 08/31/1995 | CA2184155A1 Diesters of carbonic acid endowed with antiviral and anti-inflammatory activity |
| 08/31/1995 | CA2183535A1 Antigen-based heteropolymers and method for treating autoimmune diseases using the same |
| 08/30/1995 | EP0669316A1 Analogs of 15-déoxyspergualine, process for their preparation and their use as immunosuppressive agents |
| 08/30/1995 | EP0669001A1 Determination of peptide motifs on mhc molecules. |
| 08/30/1995 | EP0668918A1 Disease associated human autoantibodies specific for human thyroid peroxidase |
| 08/30/1995 | EP0668915A1 Protein allergens of the species cynodon dactylon |
| 08/30/1995 | EP0668772A1 Specific immune system modulation |
| 08/30/1995 | EP0668771A1 Treatment of autoimmune diseases by inducing tolerance to cells, tissues and organs |
| 08/30/1995 | EP0485577B1 Immunostimulant drug based on polar glycopeptidolipids of mycobacterium chelonae |
| 08/30/1995 | EP0428541B1 Collagen wound healing matrices and process for their production |